HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4,5-dianilinophthalimide

structure given in first source
Also Known As:
CGP 52411; CGP 53353; CGP 54211; CGP-52411; CGP53353; DAPH1; 1H-Isoindole-1,3(2H)-dione, 5,6-bis(phenylamino)-
Networked: 14 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lei, Shaoqing: 3 articles (01/2020 - 08/2015)
2. Su, Wating: 2 articles (01/2020 - 01/2018)
3. Xia, Zhengyuan: 2 articles (01/2020 - 08/2015)
4. Zhang, Yuan: 2 articles (01/2020 - 01/2018)
5. Buchwald, Stephen L: 2 articles (05/2008 - 09/2005)
6. Hennessy, Edward J: 2 articles (05/2008 - 09/2005)
7. Huang, Fengnan: 1 article (01/2020)
8. Wang, Yafeng: 1 article (01/2020)
9. Xia, Zhong-Yuan: 1 article (01/2020)
10. Zhou, Lu: 1 article (01/2020)

Related Diseases

1. Hypoxia (Hypoxemia)
2. Alzheimer Disease (Alzheimer's Disease)
3. Neoplasms (Cancer)
4. Right Ventricular Hypertrophy
5. Retinoblastoma (Glioblastoma, Retinal)

Related Drugs and Biologics

1. 5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanine
2. Glucose (Dextrose)
3. Protein-Tyrosine Kinases (Tyrosine Kinase)
4. Epidermal Growth Factor (EGF)
5. 4,5-dianilinophthalimide
6. ErbB Receptors (EGF Receptor)
7. Occludin
8. Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
9. Iloprost (Ventavis)
10. Transforming Growth Factor alpha (TGF-alpha)

Related Therapies and Procedures

1. Therapeutics
2. Oral Administration